GlassScriptPhysician profile
John Murdock Rawlings
NPI 1245590744
$20,589.83
in general payments reported to CMS, 2019-2025
14 companies · $1,878 in 2025
The $1,878 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $853 · 2021: $3,573 · 2022: $12K · 2023: $1,122 · 2024: $716 · 2025: $1,878.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,490 · Food and Beverage: $1,226.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,489.77 |
| Food and Beverage | $1,225.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,056.38 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Medical Device Business Services, INC. | $5,602.57 | 2022 | |
| Djo, LLC | $3,000.00 | 2022 | |
| Arthrex, INC. | $2,330.91 | 2023-2025 | |
| Stryker Corporation | $1,069.58 | 2022-2024 | Iconix, Flexible Guide Pin (Stryker Acl Versitomic), Cobra |
| Zimmer Biomet Holdings, INC. | $853.35 | 2019 | |
| Depuy Synthes Sales INC. | $286.24 | 2021-2024 | |
| Alliance Medical | $158.22 | 2024-2025 | |
| Gemini Mountain Medical, LLC | $104.51 | 2023 | |
| Vericel Corporation | $50.90 | 2025 | Maci |
| Pacira Pharmaceuticals Incorporated | $32.09 | 2025 | Exparel |
| Organogenesis INC. | $17.58 | 2024 | |
| Ossur Americas, INC. | $14.17 | 2024 | Miami J |
| Medtronic, INC. | $13.33 | 2023 | V-Loc 180 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rawlings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.